Last reviewed 2026-05-15 · How we verify
Home › Drugs › Amsterdam UMC, location VUmc › [89Zr]Zr-Df-Crefmirlimab PET imaging [89Zr]Zr-Df-Crefmirlimab PET imaging
At a glance
Generic name [89Zr]Zr-Df-Crefmirlimab PET imaging Sponsor Amsterdam UMC, location VUmc Modality Small molecule Phase Phase 1
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
Drug Landscape https://druglandscape.com/drug/89zr-zr-df-crefmirlimab-pet-imaging · Machine-readable: markdown · JSON · Editorial policy: /editorial-policy
Not medical advice. Information on this page is collated from primary regulatory and clinical-trial sources for research purposes. It is not a substitute for consultation with a licensed healthcare professional. See our editorial policy for sourcing and methodology.